Mahesh Karande is the founder of Omega Therapeutics. Omega Therapeutics has raised $400M in total funding. Latest round: IPO. Backed by Flagship Pioneering.
Mahesh Karande is the President and CEO of Omega Therapeutics, a clinical-stage biotechnology company that trailblazes programmable epigenetic medicines through mRNA therapeutics. He has successfully raised approximately $400 million through private rounds (Series A, B, C), an IPO in July 2021, and subsequent financing for Omega.
Full founder directory · Investor directory · Company funding database · Fundraising library